Oligonucleotide Synthesis Market
Oligonucleotide Synthesis Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Product & Services (Oligonucleotide Synthesis Products (Oligonucleotide Synthesis Equipment - Synthesizers, Oligonucleotide Synthesis Reagents & Consumables), Synthesized Oligonucleotides (Pre-Designed Oligonucleotides - Primers, Probes, Linkers & Adaptors), Custom Oligonucleotide Synthesis Services (Custom Oligonucleotide - Large-Scale Oligonucleotide Synthesis, Intermediate-Scale Oligonucleotide Synthesis, Small-Scale Oligonucleotide Synthesis); By Application (Research (PCR, qPCR/RTqPCR, Sequencing, Gene Synthesis, Other Research Applications), Therapeutics (RNAi Oligonucleotide-based Therapies, DNA/Antisense oligonucleotide-based Therapies, Immunotherapy (CpG Oligonucleotide-based Therapies), Nucleic Acid Aptamers), Diagnostics); By End User (Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, Diagnostic Laboratories, Others); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
- Published Date: January 2023
- Report ID: BWC22580
- Available Format: PDF
- Page: 240
Report Overview
Rising autoimmune disease prevalence, expanding use of oligonucleotide synthesis, rising biosimilars' cost-effectiveness, rising government investments in healthcare infrastructure, and rising research and development capabilities could boost the growth of Global Oligonucleotide Synthesis Market during the forecast period between 2023 and 2029.Global Oligonucleotide Synthesis Market - Industry Trends & Forecast Report, 2029
Global oligonucleotide synthesis market size is estimated at USD 5.99 billion in 2022. During the forecast period between 2023 and 2029, the size of global oligonucleotide synthesis market is projected to grow at a CAGR of 11.6% reaching a value of USD 12.94 billion by 2029. In research, genetic testing, drug development, and forensic applications, the demand for custom-made nucleotides for the desired sequence have increased due to the falling cost of sequencing. As a result, oligonucleotide synthesis is more in demand across a variety of life science applications. Numerous ongoing genetic research studies heavily rely on oligonucleotide synthesis. The demand for a custom synthesis of various classes of oligos, such as decoys, aptamers, immunostimulatory, antisense, siRNA, and miRNA, is expected to increase as genetic research funding increases. Several significant and up-and-coming producers of oligonucleotides are working with pharmaceutical manufacturers to expand their businesses. For instance, CordenPharma International and GE Healthcare Dharmacon Inc., signed a strategic collaboration agreement in June 2017 to develop an end-to-end oligonucleotide-based drug discovery solution.
Global Oligonucleotide Synthesis Market - Overview
Short nucleic acid fragments are joined together chemically in a process known as oligonucleotide synthesis to create desired sequenced products. Researchers can alter it by the application and their needs. It is utilized in recombinant DNA technologies to create monoclonal antibodies as primers and probes. Additionally, it is used for gene expression, cloning, molecular diagnostics, and screening for genetic diseases in biological, medical, forensic, and clinical applications. Additionally, it is becoming more popular in the therapeutic use of several medications because of the development of automated reactor platforms, which make oligonucleotides available at affordable prices.
Global Oligonucleotide Synthesis Market
Growth Drivers
Falling cost of sequencing driving oligonucleotide synthesis market
Over the last few years, advances in genomics research have resulted in a significant reduction in the cost of genome sequencing. NGS technology has significantly reduced the cost and increased the speed of DNA sequencing. According to the National Human Genome Research Institute (NHGRI), the cost of sequencing a human genome has dropped significantly from about USD 5 million in 2008 to about USD 1,000 in 2017. Sequencing is increasingly being used in genomics research not only to assemble genomes and investigate the genetic basis of human diseases, but also to understand the diverse nature of reproductive medicine, oncology, and infectious diseases. As a result, the rapidly falling cost of sequencing is expected to boost research activities, fueling the demand for oligonucleotide synthesis products and technologies during the forecast period.
Significant opportunities in emerging Asian markets
For different market participants in the oligonucleotide synthesis industry, developed nations, such as the United States, have been the most important markets. But low-penetration emerging markets are expected to witness significant growth over the next few years due to an increase in oligonucleotide demand; R&D spending; proteomics, genomics, and metabolomics research; and in healthcare costs; and ongoing improvements in the healthcare system. For the past few years, market participants in the oligonucleotide synthesis industry have identified the Asia-Pacific region's emerging economies—including China, India, and Association of Southeast Asian Nations (ASEAN) members—as being particularly lucrative. The aging population, expanding healthcare system, and growing middle class in China are all contributing to the country's significant growth in the demand for genetic sequencing. For instance, in 2016, the Chinese Academy of Sciences introduced a USD 9.2-billion, 14-year project - The Precision Medicine Initiative - to sequence more than 100 million human genomes by 2030.
Restraints
In-house oligonucleotide development could affect growth of service providers
In-house oligonucleotide development has an impact on service providers' sales, according to a recent trend. Academic and research institutions are primarily responsible for this internal development. To maintain privacy and simplify manufacturing, biopharmaceutical companies have begun developing oligonucleotides themselves or have given contracts to other organizations. However, limited requirements and budgetary restrictions are impossible to monitor, which tends to reduce the market's potential. Due to a lack of resources, the global market may also experience growth restrictions. Research funding for academic laboratories is anticipated to be limited, which could restrain the growth of global oligonucleotide synthesis market. Additionally, some regions only have a small number of market participants, and there is a labor shortage. These elements might prevent the expansion of research activities in oligonucleotide synthesis.
Impact of COVID-19 on Global Oligonucleotide Synthesis Market
The newest novel coronavirus, COVID-19, is the infectious disease that it causes. Before the outbreak's start in Wuhan (China) in December 2019, COVID-19 was largely unknown. It became a global pandemic. The COVID-19 outbreak was formally classified as a pandemic by the World Health Organization (WHO). A variety of well-known pharmaceutical and biopharmaceutical firms stepped forward to support global research initiatives by offering oligo products for creating test kits, medications, and vaccines that target the infection caused by the novel Coronavirus. They joined forces with players in the oligonucleotide synthesis market. In April 2021, for example, Microsynth AG (Switzerland) provided key reagents, such as primer-probe sets to PCR testing labs to assist molecular diagnostic companies in developing and validating accurate, cutting-edge detection methods, as well as to provide comprehensive genomics expertise to research labs studying coronaviruses.
Global Oligonucleotide Synthesis Market
Segmental Coverage
Global Oligonucleotide Synthesis Market - By Product and Services
Global oligonucleotide synthesis market is divided into Oligonucleotide Synthesis Products - Oligonucleotide Synthesis Equipment (Synthesizers) and Oligonucleotide Synthesis Reagents & Consumables, Synthesized Oligonucleotides (Pre-Designed Oligonucleotides - Primers, Probes, and Linkers & Adaptors), Custom Oligonucleotide Synthesis Services (Custom Oligonucleotide - Large-Scale Oligonucleotide Synthesis, Intermediate-Scale Oligonucleotide Synthesis, and Small-Scale Oligonucleotide Synthesis). The oligonucleotide synthesis products segment is expected to account for a significant market share in the oligonucleotide synthesis market. The widespread use of synthesizers and consumables, such as PCR primers in PCR studies, has resulted in a higher proportion of synthesis products. The widespread use of PCR technologies in research and diagnostic fields, owing to their ease of use, high sensitivity, and low cost, is fueling the segment growth.
Global Oligonucleotide Synthesis Market - By Application
On basis of the application, global oligonucleotide synthesis market is divided into Research (PCR, qPCR/RTqPCR, Sequencing, Gene Synthesis, and Other Research Applications), Therapeutics (RNAi Oligonucleotide-based Therapies, DNA/Antisense oligonucleotide-based Therapies, Immunotherapy [CpG Oligonucleotide-based Therapies], and Nucleic Acid Aptamers), and Diagnostics. The research segment is expected to hold the highest market share in the global oligonucleotide synthesis market by application. However, due to the growing applications of molecular diagnostics (MDx) and genetic testing, the use of oligonucleotides for diagnostic applications is projected to grow at the fastest CAGR during the forecast period. For target screening and identification in drug development, PCR primers are frequently used. PCR primers currently hold the largest revenue share in the oligonucleotide synthesis market due to the presence of a strong pipeline of oligonucleotide-based therapeutics, including antisense therapeutics, DNA vaccines, and anti-viral agents, in various stages of clinical development.
Global Oligonucleotide Synthesis Market - By End User
On basis of end user, global oligonucleotide synthesis market is divided into Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, Diagnostic Laboratories, and other segments. Pharmaceutical and biotechnology companies are concentrating on finding alternative methods of treating diseases. As oligonucleotides provide an efficient mode of action for the treatment of a variety of indications at comparatively low development costs, these companies are heavily utilizing them. Additionally, oligonucleotides are crucial in resolving issues with the most effective drug administration route. The production of oligonucleotide therapeutics is then expected to rise, increasing the market share of pharmaceutical and biotechnology firms across countries. Infrastructure for education and research is being developed in emerging economies with funding from both public and private sources. This aspect is expected to encourage the use of oligonucleotides in academic research facilities.
Global Oligonucleotide Synthesis Market - By Region
Geographically, global oligonucleotide synthesis market covers five major markets: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Due to its rapid advancement in genomic studies, Asia Pacific is expected to record grow at the fastest rate with the rising adoption of sequencing, array technology, and PCR products. The most lucrative markets in the area for genomics investments are China and Japan. Additionally, it is expected that an increase in product launches and approvals will positively influence the market expansion. For instance, in December 2020, China approved the clinical use of Illumina's NextSeq 550Dx for use in genetic testing and diagnosis.
Competitive Landscape
Global oligonucleotide synthesis market is highly competitive. Prominent players in the market include Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Horizon Discovery Ltd., Agilent Technologies, Kaneka Eurogentec S.A., Integrated DNA Technologies, Inc., LGC Biosearch Technologies, Eurofins Genomics, General Electric, Genscript, Danaher, TriLink BioTechnologies, Biolytic Lab Performance Inc., PolyGen GmbH, Quintara Biosciences, Twist Bioscience, GENERI BIOTECH, Ionis Pharmaceuticals, and Maravai LifeSciences. The key strategies used by these market leaders are new product launches, mergers & acquisitions, and alliances. To grow their market share, these companies are also focusing on investing in innovations, collaborations, and expansions.
Recent Developments
-
In May 2022, Amerigo Scientific, a distribution company focused on providing critical products and services to the biomedical and life science communities introduced new extra-large Drying Traps (up to 4 liters of acetonitrile solution) for research application. These new DNA moisture traps can be used for maintaining moisture-free environments in oligonucleotide synthesis.
-
In April 2022, Ansa Biotech raised USD 68 million to launch a customizable DNA synthesis service, stemming from the development of a novel synthesis method. The funds will support the company’s DNA synthesis research and development efforts.
Scope of the Report
Attributes |
Details |
Years Considered |
Historical Data – 2019–2022 |
Base Year – 2022 |
|
Estimated Year – 2023 |
|
Forecast Period – 2023–2029 |
|
Facts Covered |
Revenue in USD Billion |
Market Coverage |
North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Product/ Service Segmentation |
Product & Services, Application, End User, Region |
Key Players |
Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Horizon Discovery Ltd., Agilent Technologies, Kaneka Eurogentec S.A., Integrated DNA Technologies, Inc., LGC Biosearch Technologies, Eurofins Genomics, General Electric, Genscript, Danaher, TriLink BioTechnologies, Biolytic Lab Performance Inc., PolyGen GmbH, Quintara Biosciences, Twist Bioscience, GENERI BIOTECH, Ionis Pharmaceuticals, Maravai LifeSciences |
By Product & Services
-
Oligonucleotide Synthesis Products
-
Oligonucleotide Synthesis Equipment (Synthesizers)
-
Oligonucleotide Synthesis Reagents & Consumables
-
Synthesized Oligonucleotides (Pre-Designed Oligonucleotides)
-
Primers
-
Probes
-
Linkers & Adaptors
-
Custom Oligonucleotide Synthesis Services (Custom Oligonucleotide)
-
Large-Scale Oligonucleotide Synthesis
-
Intermediate-Scale Oligonucleotide Synthesis
-
Small-Scale Oligonucleotide Synthesis
By Application
-
Research
-
PCR
-
qPCR/RTqPCR
-
Sequencing
-
Gene Synthesis
-
Other Research Applications
-
Therapeutics
-
RNAi Oligonucleotide-based Therapies
-
DNA/Antisense oligonucleotide-based Therapies
-
Immunotherapy (CpG Oligonucleotide-based Therapies)
-
Nucleic Acid Aptamers
-
Diagnostics
By End User
-
Pharmaceutical and Biotechnology Companies
-
Academic & Research Institutes
-
Diagnostic Laboratories
-
Others
By Region
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East and Africa
- Research Framework
- Research Objective
- Product Overview
- Market Segmentation
- Executive Summary
- Global Oligonucleotide Synthesis Market Insights
- Industry Value Chain Analysis
- DROC Analysis
- Growth Drivers
- Rising prevalence of autoimmune diseases
- Increasing adoption of Oligonucleotide Synthesis
- Growing number of cost-effective biosimilars
- Restraints
- Complexities in manufacturing
- Opportunities
- Rising research and development proficiencies
- Growing government investments on healthcare infrastructure
- Challenges
- Lack of standard protocols for developing software platforms
- Energy demand soars as EV sales soar
- Growth Drivers
- Product Advancements/Recent Developments
- Regulatory Framework
- Porter’s Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of New Entrants
- Threat of Substitutes
- Intensity of Rivalry
- Global Oligonucleotide Synthesis Market Overview
- Market Size & Forecast, 2019–2029
- By Value (USD Billion)
- Market Share & Forecast
- By Product & Services
- Oligonucleotide Synthesis Products
- Oligonucleotide Synthesis Equipment (Synthesizers)
- Oligonucleotide Synthesis Reagents & Consumables
- Synthesized Oligonucleotides (Pre-Designed Oligonucleotides)
- Primers
- Probes
- Linkers & Adaptors
- Custom Oligonucleotide Synthesis Services (Custom Oligonucleotide)
- Large-Scale Oligonucleotide Synthesis
- Intermediate-Scale Oligonucleotide Synthesis
- Small-Scale Oligonucleotide Synthesis
- Oligonucleotide Synthesis Products
- By Application
- Research
- PCR
- qPCR/RTqPCR
- Sequencing
- Gene Synthesis
- Other Research Applications
- Therapeutics
- RNAi Oligonucleotide-based Therapies
- DNA/Antisense oligonucleotide-based Therapies
- Immunotherapy (CpG Oligonucleotide-based Therapies)
- Nucleic Acid Aptamers
- Diagnostics
- Research
- By End User
- Pharmaceutical and Biotechnology Companies
- Academic & Research Institutes
- Diagnostic Laboratories
- Others
- By Region
- North America
- Europe
- Asia Pacific (APAC)
- Latin America
- Middle East and Africa (MEA)
- By Product & Services
- Market Size & Forecast, 2019–2029
- North America Oligonucleotide Synthesis Market
-
- Market Size & Forecast, 2019–2029
- By Value (USD Billion)
- Market Share & Forecast
- By Product & Services
- By Application
- By End User
- By Country
- United States
- By Product & Services
- By Application
- By End User
- Canada
- By Product & Services
- By Application
- By End User
- United States
-
- Europe Oligonucleotide Synthesis Market
- Market Size & Forecast, 2019–2029
- By Value (USD Billion)
- Market Share & Forecast
- By Product & Services
- By Application
- By End User
- By Country
- Germany
- By Product & Services
- By Application
- By End User
- United Kingdom
- By Product & Services
- By Application
- By End User
- Italy
- By Product & Services
- By Application
- By End User
- France
- By Product & Services
- By Application
- By End User
- Spain
- By Product & Services
- By Application
- By End User
- The Netherlands
- By Product & Services
- By Application
- By End User
- Belgium
- By Product & Services
- By Application
- By End User
- NORDIC Countries
- By Product & Services
- By Application
- By End User
- Rest of Europe
- By Product & Services
- By Application
- By End User
- Germany
- Market Size & Forecast, 2019–2029
- Asia-Pacific Oligonucleotide Synthesis Market
- Market Size & Forecast, 2019–2029
- By Value (USD Billion)
- Market Share & Forecast
- By Product & Services
- By Application
- By End User
- By Country
- China
- By Product & Services
- By Application
- By End User
- India
- By Product & Services
- By Application
- By End User
- Japan
- By Product & Services
- By Application
- By End User
- South Korea
- By Product & Services
- By Application
- By End User
- Australia & New Zealand
- By Product & Services
- By Application
- By End User
- Indonesia
- By Product & Services
- By Application
- By End User
- Malaysia
- By Product & Services
- By Application
- By End User
- Singapore
- By Product & Services
- By Application
- By End User
- Philippines
- By Product & Services
- By Application
- By End User
- Vietnam
- By Product & Services
- By Application
- By End User
- Rest of Asia Pacific
- By Product & Services
- By Application
- By End User
- China
- Market Size & Forecast, 2019–2029
- Latin America Oligonucleotide Synthesis Market
- Market Size & Forecast, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Product & Services
- By Application
- By End User
- By Country
- Brazil
- By Product & Services
- By Application
- By End User
- Mexico
- By Product & Services
- By Application
- By End User
- Argentina
- By Product & Services
- By Application
- By End User
- Peru
- By Product & Services
- By Application
- By End User
- Colombia
- By Product & Services
- By Application
- By End User
- Rest of Latin America
- By Product & Services
- By Application
- By End User
- Brazil
- Market Size & Forecast, 2019–2029
- Middle East & Africa Oligonucleotide Synthesis Market
- Market Size & Forecast, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Product & Services
- By Application
- By End User
- By Country
- Saudi Arabia
- By Product & Services
- By Application
- By End User
- UAE
- By Product & Services
- By Application
- By End User
- Qatar
- By Product & Services
- By Application
- By End User
- Kuwait
- By Product & Services
- By Application
- By End User
- Iran
- By Product & Services
- By Application
- By End User
- South Africa
- By Product & Services
- By Application
- By End User
- Nigeria
- By Product & Services
- By Application
- By End User
- Kenya
- By Product & Services
- By Application
- By End User
- Egypt
- By Product & Services
- By Application
- By End User
- Morocco
- By Product & Services
- By Application
- By End User
- Algeria
- By Product & Services
- By Application
- By End User
- Rest of Middle East & Africa
- By Product & Services
- By Application
- By End User
- Saudi Arabia
- Market Size & Forecast, 2019–2029
- Competitive Landscape
- List of Key Players and Their Offerings
- Global Essential Oils Company Market Share Analysis, 2021
- Competitive Benchmarking, By Operating Parameters
- Key Strategic Developments (Mergers, Acquisitions, Partnerships, and others)
- Impact of Covid-19 on Global Oligonucleotide Synthesis Market
- Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
- Thermo Fisher Scientific
- Merck KGaA
- GE Healthcare
- Horizon Discovery Ltd.
- Agilent Technologies
- Kaneka Eurogentec S.A.
- Integrated DNA Technologies, Inc.
- LGC Biosearch Technologies
- Eurofins Genomics
- General Electric
- Genscript
- Danaher
- TriLink BioTechnologies
- Biolytic Lab Performance Inc.
- PolyGen GmbH
- Quintara Biosciences
- Twist Bioscience
- GENERI BIOTECH
- Ionis Pharmaceuticals
- Maravai LifeSciences
- Other Prominent Players
- Key Strategic Recommendations
- Research Methodology
- Qualitative Research
- Primary & Secondary Research
- Quantitative Research
- Market Breakdown & Data Triangulation
- Secondary Research
- Primary Research
- Breakdown of Primary Research Respondents, By Region
- Assumptions & Limitations
- Qualitative Research
*Financial information in case of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.
List of Figures
Figure 1 Global Oligonucleotide Synthesis Market Segmentation
Figure 2 Global Oligonucleotide Synthesis Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2021
Figure 4 Global Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029
Figure 5 Global Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 6 Global Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 7 Global Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 8 Global Oligonucleotide Synthesis Market Share, By Region, By Value, 2019–2029
Figure 9 North America Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029
Figure 10 North America Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 11 North America Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 12 North America Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 13 North America Oligonucleotide Synthesis Market Share, By Country, By Value, 2019–2029
Figure 14 United States Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029
Figure 15 United States Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 16 United States Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 17 United States Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 18 Canada Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 19 Canada Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 20 Canada Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 21 Canada Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 22 Europe Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029
Figure 23 Europe Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 24 Europe Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 25 Europe Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 26 Europe Oligonucleotide Synthesis Market Share, By Country, By Value, 2019–2029
Figure 27 Germany Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 28 Germany Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 29 Germany Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 30 Germany Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 31 UK Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 32 UK Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 33 UK Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 34 UK Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 35 Italy Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 36 Italy Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 37 Italy Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 38 Italy Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 39 France Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 40 France Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 41 France Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 42 France Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 43 Spain Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 44 Spain Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 45 Spain Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 46 Spain Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 47 The Netherlands Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 48 The Netherlands Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 49 The Netherlands Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 50 The Netherlands Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 51 Belgium Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 52 Belgium Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 53 Belgium Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 54 Belgium Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 55 NORDIC Countries Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 56 NORDIC Countries Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 57 NORDIC Countries Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 58 NORDIC Countries Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 59 Rest of Europe Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 60 Rest of Europe Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 61 Rest of Europe Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 62 Rest of Europe Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 63 Asia-Pacific Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029
Figure 64 Asia-Pacific Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 65 Asia-Pacific Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 66 Asia-Pacific Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 67 Asia-Pacific Oligonucleotide Synthesis Market Share, By Country, By Value, 2019–2029
Figure 68 China Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 69 China Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 70 China Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 71 China Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 72 India Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 73 India Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 74 India Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 75 India Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 76 Japan Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 77 Japan Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 78 Japan Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 79 Japan Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 80 South Korea Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 81 South Korea Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 82 South Korea Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 83 South Korea Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 84 Australia & New Zealand Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 85 Australia & New Zealand Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 86 Australia & New Zealand Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 87 Australia & New Zealand Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 88 Indonesia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 89 Indonesia Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 90 Indonesia Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 91 Indonesia Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 92 Malaysia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 93 Malaysia Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 94 Malaysia Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 95 Malaysia Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 96 Singapore Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 97 Singapore Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 98 Singapore Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 99 Singapore Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 100 Philippines Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 101 Philippines Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 102 Philippines Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 103 Philippines Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 104 Vietnam Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 105 Vietnam Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 106 Vietnam Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 107 Vietnam Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 108 Rest of APAC Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 109 Rest of APAC Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 110 Rest of APAC Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 111 Rest of APAC Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 112 Latin America Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 113 Latin America Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 114 Latin America Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 115 Latin America Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 116 Latin America Oligonucleotide Synthesis Market Share, By Country, By Value, 2019–2029
Figure 117 Brazil Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 118 Brazil Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 119 Brazil Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 120 Brazil Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 121 Mexico Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 122 Mexico Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 123 Mexico Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 124 Mexico Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 125 Argentina Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 126 Argentina Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 127 Argentina Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 128 Argentina Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 129 Peru Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 130 Peru Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 131 Peru Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 132 Peru Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 133 Colombia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 134 Colombia Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 135 Colombia Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 136 Colombia Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 137 Rest of LATAM Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 138 Rest of LATAM Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 139 Rest of LATAM Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 140 Rest of LATAM Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 141 Middle East & Africa Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 142 Middle East & Africa Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 143 Middle East & Africa Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 144 Middle East & Africa Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 145 Middle East & Africa Oligonucleotide Synthesis Market Share, By Country, By Value, 2019–2029
Figure 146 Saudi Arabia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 147 Saudi Arabia Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 148 Saudi Arabia Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 149 Saudi Arabia Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 150 UAE Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 151 UAE Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 152 UAE Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 153 UAE Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 154 Qatar Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 155 Qatar Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 156 Qatar Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 157 Qatar Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 158 Kuwait Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 159 Kuwait Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 160 Kuwait Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 161 Kuwait Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 162 Iran Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 163 Iran Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 164 Iran Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 165 Iran Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 166 South Africa Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 167 South Africa Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 168 South Africa Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 169 South Africa Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 170 Nigeria Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 171 Nigeria Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 172 Nigeria Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 173 Nigeria Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 174 Kenya Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 175 Kenya Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 176 Kenya Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 177 Kenya Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 178 Egypt Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 179 Egypt Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 180 Egypt Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 181 Egypt Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 182 Morocco Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 183 Morocco Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 184 Morocco Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 185 Morocco Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 186 Algeria Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 187 Algeria Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 188 Algeria Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 189 Algeria Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
Figure 190 Rest of Middle East & Africa Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Figure 191 Rest of Middle East & Africa Oligonucleotide Synthesis Market Share, By Product & Services, By Value, 2019–2029
Figure 192 Rest of Middle East & Africa Oligonucleotide Synthesis Market Share, By Application, By Value, 2019–2029
Figure 193 Rest of Middle East & Africa Oligonucleotide Synthesis Market Share, By End User, By Value, 2019–2029
List of Tables
Table 1 Global Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 2 Global Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 3 Global Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 4 Global Oligonucleotide Synthesis Market Size, By Region, By Value, 2019–2029
Table 5 North America Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029
Table 6 North America Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 7 North America Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 8 North America Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 9 North America Oligonucleotide Synthesis Market Size, By Country, By Value, 2019–2029
Table 10 United States Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029
Table 11 United States Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 12 United States Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 13 United States Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 14 Canada Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 15 Canada Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 16 Canada Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 17 Canada Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 18 Europe Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029
Table 19 Europe Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 20 Europe Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 21 Europe Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 22 Europe Oligonucleotide Synthesis Market Size, By Country, By Value, 2019–2029
Table 23 Germany Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 24 Germany Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 25 Germany Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 26 Germany Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 27 UK Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 28 UK Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 29 UK Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 30 UK Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 31 Italy Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 32 Italy Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 33 Italy Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 34 Italy Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 35 France Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 36 France Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 37 France Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 38 France Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 39 Spain Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 40 Spain Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 41 Spain Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 42 Spain Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 43 The Netherlands Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 44 The Netherlands Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 45 The Netherlands Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 46 The Netherlands Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 47 Belgium Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 48 Belgium Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 49 Belgium Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 50 Belgium Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 51 NORDIC Countries Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 52 NORDIC Countries Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 53 NORDIC Countries Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 54 NORDIC Countries Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 55 Rest of Europe Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 56 Rest of Europe Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 57 Rest of Europe Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 58 Rest of Europe Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 59 Asia-Pacific Oligonucleotide Synthesis Market Size, By Value (USD Billion), 2019–2029
Table 60 Asia-Pacific Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 61 Asia-Pacific Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 62 Asia-Pacific Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 63 Asia-Pacific Oligonucleotide Synthesis Market Size, By Country, By Value, 2019–2029
Table 64 China Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 65 China Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 66 China Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 67 China Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 68 India Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 69 India Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 70 India Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 71 India Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 72 Japan Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 73 Japan Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 74 Japan Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 75 Japan Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 76 South Korea Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 77 South Korea Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 78 South Korea Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 79 South Korea Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 80 Australia & New Zealand Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 81 Australia & New Zealand Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 82 Australia & New Zealand Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 83 Australia & New Zealand Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 84 Indonesia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 85 Indonesia Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 86 Indonesia Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 87 Indonesia Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 88 Malaysia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 89 Malaysia Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 90 Malaysia Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 91 Malaysia Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 92 Singapore Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 93 Singapore Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 94 Singapore Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 95 Singapore Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 96 Philippines Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 97 Philippines Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 98 Philippines Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 99 Philippines Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 100 Vietnam Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 101 Vietnam Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 102 Vietnam Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 103 Vietnam Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 104 Rest of APAC Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 105 Rest of APAC Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 106 Rest of APAC Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 107 Rest of APAC Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 108 Latin America Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 109 Latin America Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 110 Latin America Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 111 Latin America Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 112 Latin America Oligonucleotide Synthesis Market Size, By Country, By Value, 2019–2029
Table 113 Brazil Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 114 Brazil Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 115 Brazil Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 116 Brazil Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 117 Mexico Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 118 Mexico Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 119 Mexico Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 120 Mexico Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 121 Argentina Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 122 Argentina Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 123 Argentina Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 124 Argentina Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 125 Peru Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 126 Peru Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 127 Peru Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 128 Peru Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 129 Colombia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 130 Colombia Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 131 Colombia Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 132 Colombia Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 133 Rest of LATAM Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 134 Rest of LATAM Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 135 Rest of LATAM Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 136 Rest of LATAM Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 137 Middle East & Africa Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 138 Middle East & Africa Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 139 Middle East & Africa Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 140 Middle East & Africa Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 141 Middle East & Africa Oligonucleotide Synthesis Market Size, By Country, By Value, 2019–2029
Table 142 Saudi Arabia Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 143 Saudi Arabia Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 144 Saudi Arabia Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 145 Saudi Arabia Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 146 UAE Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 147 UAE Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 148 UAE Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 149 UAE Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 150 Qatar Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 151 Qatar Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 152 Qatar Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 153 Qatar Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 154 Kuwait Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 155 Kuwait Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 156 Kuwait Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 157 Kuwait Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 158 Iran Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 159 Iran Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 160 Iran Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 161 Iran Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 162 South Africa Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 163 South Africa Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 164 South Africa Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 165 South Africa Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 166 Nigeria Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 167 Nigeria Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 168 Nigeria Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 169 Nigeria Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 170 Kenya Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 171 Kenya Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 172 Kenya Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 173 Kenya Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 174 Egypt Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 175 Egypt Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 176 Egypt Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 177 Egypt Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 178 Morocco Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 179 Morocco Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 180 Morocco Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 181 Morocco Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 182 Algeria Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 183 Algeria Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 184 Algeria Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 185 Algeria Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 186 Rest of Middle East & Africa Oligonucleotide Synthesis Market Size, By Value (USD Million), 2019–2029
Table 187 Rest of Middle East & Africa Oligonucleotide Synthesis Market Size, By Product & Services, By Value, 2019–2029
Table 188 Rest of Middle East & Africa Oligonucleotide Synthesis Market Size, By Application, By Value, 2019–2029
Table 189 Rest of Middle East & Africa Oligonucleotide Synthesis Market Size, By End User, By Value, 2019–2029
Table 190 Thermo Fisher Scientific Company Overview
Table 191 Thermo Fisher Scientific Financial Overview
Table 192 Merck KGaA Company Overview
Table 193 Merck KGaA Financial Overview
Table 194 GE Healthcare Company Overview
Table 195 GE Healthcare Financial Overview
Table 196 Horizon Discovery Ltd. Company Overview
Table 197 Horizon Discovery Ltd. Financial Overview
Table 198 Agilent Technologies Company Overview
Table 199 Agilent Technologies Financial Overview
Table 200 Kaneka Eurogentec S.A. Company Overview
Table 201 Kaneka Eurogentec S.A. Financial Overview
Table 202 Integrated DNA Technologies, Inc. Company Overview
Table 203 Integrated DNA Technologies, Inc. Financial Overview
Table 204 LGC Biosearch Technologies Company Overview
Table 205 LGC Biosearch Technologies Financial Overview
Table 206 Eurofins Genomics Company Overview
Table 207 Eurofins Genomics Financial Overview
Table 208 General Electric Company Overview
Table 209 General Electric Financial Overview
Table 210 Genscript Company Overview
Table 211 Genscript Financial Overview
Table 212 Danaher Company Overview
Table 213 Danaher Financial Overview
Table 214 TriLink BioTechnologies Company Overview
Table 215 TriLink BioTechnologies Financial Overview
Table 216 Biolytic Lab Performance Inc. Company Overview
Table 217 Biolytic Lab Performance Inc. Financial Overview
Table 218 PolyGen GmbH Company Overview
Table 219 PolyGen GmbH Financial Overview
Table 220 Quintara Biosciences Company Overview
Table 221 Quintara Biosciences Financial Overview
Table 222 Twist Bioscience Company Overview
Table 223 Twist Bioscience Financial Overview
Table 224 GENERI BIOTECH Company Overview
Table 225 GENERI BIOTECH Financial Overview
Table 226 Ionis Pharmaceuticals Company Overview
Table 227 Ionis Pharmaceuticals Financial Overview
Table 228 Maravai LifeSciences Company Overview
Table 229 Maravai LifeSciences Financial Overview
Market Segmentation
By Product & Services
-
Oligonucleotide Synthesis Products
-
Oligonucleotide Synthesis Equipment (Synthesizers)
-
Oligonucleotide Synthesis Reagents & Consumables
-
Synthesized Oligonucleotides (Pre-Designed Oligonucleotides)
-
Primers
-
Probes
-
Linkers & Adaptors
-
Custom Oligonucleotide Synthesis Services (Custom Oligonucleotide)
-
Large-Scale Oligonucleotide Synthesis
-
Intermediate-Scale Oligonucleotide Synthesis
-
Small-Scale Oligonucleotide Synthesis
By Application
-
Research
-
PCR
-
qPCR/RTqPCR
-
Sequencing
-
Gene Synthesis
-
Other Research Applications
-
Therapeutics
-
RNAi Oligonucleotide-based Therapies
-
DNA/Antisense oligonucleotide-based Therapies
-
Immunotherapy (CpG Oligonucleotide-based Therapies)
-
Nucleic Acid Aptamers
-
Diagnostics
By End User
-
Pharmaceutical and Biotechnology Companies
-
Academic & Research Institutes
-
Diagnostic Laboratories
-
Others
By Region
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East and Africa
To request a free sample copy of this report, please complete the form below.
We value your investment and offer free customization with every report to fulfil your exact research needs.
Frequently Asked Questions (FAQs):
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research Support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Custom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.